SOLACI-CACI 2021 | Day 2: Main Arena Auditorium

✔️ Day 2, SOLACI-CACI 2021
✔️ Main Arena Auditorium

👨‍🏫 Program:

  • 00:01 – TCT@SOLACI-CACI 2021 Session: “Structural Heart Interventions”
  • 01:30:26 – CRT@SOLACI-CACI 2021 Session
  • 02:51:13 – Oral presentation – Structural II
  • 04:18:36 – Oral presentation – Coronary II
  • 05:39:29 – IAGS@SOLACI-CACI 2021 Session
  • 07:16:45 – Abbott Symposium – Using the MLD MAX Algorithm in OCT-Guided Percutaneous Coronary Interventions

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-CACI 2021 | Day 1: Main Arena Auditorium

✔️ Day 1, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 06:20 - TCT@SOLACI-CACI 2021 Session - "The Future of PCI" 01:33:19 - PCR@SOLACI-CACI 2021 Session 👉...

SOLACI-CACI 2021 | Day 3: Main Arena Auditorium

✔️ Day 3 Completo, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:05 - CBS@SOLACI-CACI Session 01:43:26 - CCI@SOLACI-CACI Session 03:07:38 - Oral presentation – Structural III 04:32:21 -...

SOLACI-CACI 2021 | Day 4: Main Arena Auditorium

✔️ Day 4, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:09 - The MIL Group/SOLACI/CACI/WAO Gender Opportunities in Interventional Cardiology 01:30:55 - Current and Immediate...

SOLACI-CACI 2021 | Day 5: Salón Main Arena

✔️ Day 5, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:06 - DAPT Session 01:48:31 - Cardiovascular Disease Management and Cath Lab During the COVID-19...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....